The Rare Diseases Clinical Research Network would like to welcome our 14 new consortia! For more information, please see below, and stay tuned for future updates!

Welcome

You have reached the home page for the Rare Diseases Clinical Research Network (RDCRN). Each Consortium within the network provides detailed information on several rare diseases.

Important Update

Please be advised that some of our consortia will be continuing their research outside of our network and their information will no longer be found within the network web sites.

As we make this transition, we will provide our patients and families with available web sites or contact information so that you may continue to be in contact with your rare disease consortium.

The following consortia will no longer be operating within the Rare Diseases Clinical Research Network. Please click on one of the links below for more information:

CLiC - Cholestatic Liver Disease Consortium
  • PFIC (Progressive Familial Intrahepatic Cholestasis)
  • Bile Acid Synthesis Defects
  • Alagille Syndrome
  • Alpha One Antitrypsin Deficiency
  • Mitochondrial Hepatopathies
Rare Genetic Steroid Disorders Consortium
  • Congenital Adrenal Hyperplasia
  • Androgen Receptor Defects
  • Apparent Mineralocorticoid Excess (Low Renin Hypertension)
Bone Marrow Failure Consortium
  • Aplastic Anemia
  • Myelodysplastic Syndromes
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Large Granular Lymphocyte (LGL) Leukemia
  • Single Lineage Cytopenias:
  • - Pure Red Cell Aplasia
    - Amegakaryocytic Thrombocytopenic Purpura
    - Autoimmune Neutropenia
Rare Lung Diseases Consortium
  • Hereditary Interstitial Lung Disease (hILD)
  • Lymphangioleiomyomatosis (LAM)
  • Pulmonary Alveolar Proteinosis (PAP)
  • Alpha-1 Antitrypsin Deficiency (Alpha-1)
Rare Thrombotic Diseases Consortium
  • Antiphospholipid Antibody Syndromes (APS)
  • Heparin-induced Thrombocytopenia (HIT)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Catastrophic Antiphospholipid Antibody Syndrome (Thrombotic Storm)
  • Thrombotic Thrombocytopenic Purpura (TTP)


Where do I need to go?

What if I am unsure of which consortium to visit?

Scan the list to the right for a disease name. Once you have located it, click on the link for a brief description which will lead you to the correct consortium.

How will this consortium be useful to me?

You can take action! Once you have reached the correct consortium, you will be able to join the contact registry for clinical research trials. You will also find several helpful resources that include participating clinical center information, support and advocacy group information and other useful links.

bullet Active Clinical Research Consortia:

Angelman, Rett, and Prader-Willi Syndromes Consortium

[Study Information]

CINCH - Consortium for Clinical Investigation of Neurological Channelopathies

[Study Information]

Vasculitis Clinical Research Consortium

[Study Information]

Genetic Diseases of Mucociliary Clearance Consortium

[Study Information]

 

Urea Cycle Disorders Consortium

[Study Information]

 

   

Our New Consortia:

Autonomic Rare Diseases Clinical Research Consortium

Brain Vascular Malformation Consortium

Dystonia Coalition

Hereditary Causes of Nephrolithaisis and Kidney Failure Consortium

Immune Disorders After Allogeneic HTC Consortium

Inherited Neuropathies Consortium

Lysosmal Disease Consortium

Nephrotic Syndrome Consortium

Primary Immune Deficiency Treatement Consortium

Sterol and Isoprenoid Diseases Consortium

Molecular and Epidemiologic Characterization of Salivary Gland Carcinmonas Consortium

Porphyria Rare Disease Clinical Research Consortium

Spinocerebellar Ataxias Clinical Research Consortium

North America Mitochondrial Diseases Consortium

 


View all RDCRN open studies >>>


Rare Diseases Clinical Research Network Member Login

Rare Diseases Media Center

CPAG Web Site

 

About the RDCRN
The Rare Diseases Clinical Research Network (RDCRN) was created to facilitate collaboration among experts in many different types of rare diseases. Our goal is to contribute to the research and treatment of rare diseases by working together to identify biomarkers for disease risk, disease severity and activity, and clinical outcome, while also encouraging development of new approaches to diagnosis, prevention, and treatment.